NDC 13537-303-01 - ESIKA Extreme Moisturizing SPF 16
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13537-303
- Requested NDC
- 13537-303-01
- Package NDCs from labels
- 13537-303-01, 13537-303-02
- Manufacturer
- Ventura Corporation (San Juan, P.R) | Bel Star S.A. (Colombia)
- Effective date
- 2011-05-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| OCTINOXATE - Ventura Corporation (San Juan, P.R) | Bel Star S.A. (Colombia) | Ventura Corporation (San Juan, P.R) | Bel Star S.A. (Colombia) | 2011-05-18 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 13537-303-02 | 2025-05-06 | C162847 | 48780-1 | 960f7f55-c18b-8e05-e053-dbdaa90a074a | ēsika Extreme Moisturizing Lipstick SPF 16 |
| 13537-303-02 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c18b-8e05-e053-dbdaa90a074a | ēsika Extreme Moisturizing Lipstick SPF 16 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HERA SILKYSTAY FOUNDATION 45N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4326fc-b3c3-1a8b-e063-6294a90a8d9b | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 45W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4335c8-596f-3269-e063-6294a90a6c3d | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 46W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f43404e-bdab-3f4b-e063-6294a90ab881 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 47N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f435148-dcb1-cfdf-e063-6394a90aa8b6 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 50N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f43610f-6c4f-dd9d-e063-6394a90ab60a | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 48N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4372c4-b87a-91ab-e063-6294a90a6807 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 49C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4380d1-2cf4-1fd8-e063-6394a90a0aa3 | 2026-11-01 | Warnings | 15FIX9V2JP |
| Hemorrhoid Anesthetic | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Savvy Care and Cosmetics | 5f0afbf4-3a61-1aab-e063-6394a90a3fe6 | 2026-10-30 | Warnings | 4T6H12BN9U |
| Delflex | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | a98facd6-9daa-4d37-8209-63a0599dbfaa | 2026-10-30 | Warnings, Adverse reactions | 02F3473H9O 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | c29bdfa0-4976-11e2-939b-0002a5d5c51b | 2026-10-30 | Warnings, Adverse reactions | 02F3473H9O 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | bbc5b820-4973-11e2-a192-0002a5d5c51b | 2026-10-30 | Warnings, Adverse reactions | 02F3473H9O 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | 515dcee0-3e34-11e2-a25f-0800200c9a66 | 2026-10-30 | Warnings, Adverse reactions | 02F3473H9O 451W47IQ8X |
| Potassium Chloride | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 47a87fb6-5e61-41c9-b759-10f7c74a67ce | 2026-10-30 | Warnings, Adverse reactions | 660YQ98I10 |
| BiologixCare Sterile Saline Wound Wash | SODIUM CHLORIDE | BIOLOGIX USA, INC. | 5e74e26d-fe34-8784-e063-6394a90ae194 | 2026-10-29 | Warnings | 451W47IQ8X |
| BiologixCare Sterile Saline Wound Wash | SODIUM CHLORIDE | BIOLOGIX USA, INC. | 5ed79ba5-43a0-c323-e063-6394a90a4618 | 2026-10-29 | Warnings | 451W47IQ8X |
| BiologixCare Sterile Saline Wound Wash | SODIUM CHLORIDE | BIOLOGIX USA, INC. | 5eda970a-6fe4-8af3-e063-6394a90a5762 | 2026-10-29 | Warnings | 451W47IQ8X |
| BiologixCare Sterile Saline Wound Wash | SODIUM CHLORIDE | BIOLOGIX USA, INC. | 5edb1f1e-122d-f0da-e063-6394a90a4ccd | 2026-10-29 | Warnings | 451W47IQ8X |
| BiologixCare Sterile Saline Wound Wash | SODIUM CHLORIDE | BIOLOGIXUSA, INC. | 5ede6a14-cc47-8423-e063-6294a90a58c5 | 2026-10-29 | Warnings | 451W47IQ8X |
| Note Mattifying Extreme Wear Foundation 03 Medium Beige | OCTINOXATE | ALTONA COSMETICS TECHNOLOGY SANAYI VE TICARET ANONIM SIRKETI | feac1cc2-eb4c-43da-89fc-6c950202b00d | 2026-10-29 | Warnings | 4Y5P7MUD51 |
| Note Mattifying Extreme Wear Foundation 04 Sand | OCTINOXATE | ALTONA COSMETICS TECHNOLOGY SANAYI VE TICARET ANONIM SIRKETI | f98d560c-6a8c-4e76-8f76-9482979c4096 | 2026-10-29 | Warnings | 4Y5P7MUD51 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.